Home/Filings/4/0001127602-24-013718
4//SEC Filing

Tarr Mark J 4

Accession 0001127602-24-013718

CIK 0000785161other

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 11:47 AM ET

Size

12.6 KB

Accession

0001127602-24-013718

Insider Transaction Report

Form 4
Period: 2024-04-30
Tarr Mark J
Executive VP Operations
Transactions
  • Sale

    Encompass Health Common Stock

    2024-04-30$83.27/sh44,976$3,745,152554,098 total
  • Exercise/Conversion

    Encompass Health Common Stock

    2024-04-30$35.83/sh+19,460$697,252573,558 total
  • Exercise/Conversion

    Encompass Health Common Stock

    2024-04-30$29.06/sh+25,516$741,495599,074 total
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2024-04-3019,4600 total
    Exercise: $35.83From: 2016-03-03Exp: 2025-03-03Encompass Health Common Stock (19,460 underlying)
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2024-04-3025,5160 total
    Exercise: $29.06From: 2017-02-26Exp: 2026-02-26Encompass Health Common Stock (25,516 underlying)
Footnotes (2)
  • [F1]This per share price is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $83.25 to $83.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
  • [F2]The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.

Issuer

Encompass Health Corp

CIK 0000785161

Entity typeother

Related Parties

1
  • filerCIK 0001304057

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 11:47 AM ET
Size
12.6 KB